Effect of chronic lead treatment on renal function.
D000085:Acetates / Q000494:pharmacology; D000618:Aminohippuric Acids / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose; D001806:Blood Urea Nitrogen; D001834:Body Water / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002247:Carbon Isotopes; D002712:Chlorides / Q000494:pharmacology; D005260:Female; D005943:Gluconeogenesis / Q000187:drug effects; D066298:In Vitro Techniques; D007668:Kidney / Q000033:anatomy & histology / Q000187:drug effects*; D007672:Kidney Cortex / Q000378:metabolism; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism; D007854:Lead / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009929:Organ Size; D010101:Oxygen Consumption / Q000187:drug effects; D011247:Pregnancy; D011773:Pyruvates / Q000378:metabolism; D000644:Quaternary Ammonium Compounds / Q000378:metabolism; D051381:Rats; D013997:Time Factors
D000085:Acetates; D000618:Aminohippuric Acids; D001786:Blood Glucose; D002247:Carbon Isotopes; D002712:Chlorides; D011773:Pyruvates; D000644:Quaternary Ammonium Compounds; D007854:Lead